01 · Process stage
PlannedCultivation parameters
Define the cell line requirements, primary growth conditions and parameters for target biological expression.
Capabilities · Drug substance & biological inputs
Protein raw-material production & purification
A proposed service scope for biological inputs, connecting initial cultivation, target molecule recovery, directed purification and intermediate characterisation.
PlannedInitial project scope
Service statusPlanned
Planned.
Technical boundaries and readiness need confirmation before an activity could be presented as available.
Basis · Initial project scope
- Status
- PlannedNo available service asserted
- Source-plan relationship
- Initial project scopeDocumented in the 15 June 2026 project plan
- Readiness
- Not establishedProduct and process evidence needed
- Facility roadmap
- First commercial batch target Q1 2028 · indicativeNot a service date
01 · Proposed service scope
Start with the product and its container.
Protein production and purification is presented as a planned service domain. The precise molecule, chosen expression system and downstream technical route would dictate its eventual boundaries.
The initial Boten project plan identifies protein raw-material production and purification as a distinct planned module, separate from the primary formulation and filling scope for injectables.
Upstream cell cultivation and downstream protein purification represent distinct technical subjects. Inclusion in one planned module does not establish that every purification sequence would suit an upstream platform.
Catalogue boundary
A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.
02 · Presentation families
Match the route to the format.
| Format | Planning note | Basis | Status |
|---|---|---|---|
| Protein raw materials | Protein raw-material production identified as a distinct module in the source plan. | Initial project scope | Planned |
| Recombinant productsBiological drug-substance development | Proposed biological processing extensions would require separate scope confirmation before advancing. | Catalogue scope | Planned |
| Purified intermediates | Intermediate materials would need appropriate technical assessment and validated analytical testing methods. | Catalogue scope | Planned |
03 · Process scope for discussion
Make the sequence and its evidence visible.
02 · Process stage
PlannedInitial biological harvest
Consider the required separation steps, cellular disruption techniques and initial clarification of the harvest.
03 · Process stage
PlannedDirected molecule purification
Identify the intended chromatography sequences that would isolate the specified protein from process impurities.
04 · Process stage
PlannedViral clearance strategies
Define the viral inactivation or removal stages strictly appropriate for the biological input material.
05 · Process stage
PlannedBulk intermediate filtration
Consider final buffer exchange, concentration steps and any terminal filtration prior to intermediate storage.
06 · Process stage
PlannedTesting and release
Connect the processing record to analytical evaluation for identity, purity and specified biochemical properties.
Illustrative sequence
This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.
04 · Supporting services
No service stands alone.
01PlannedCatalogue scope
Biological drug-substance development
Proposed biological process and material-characterisation scope.
Explore proposed scope02PlannedInitial project scope
Aseptic filling of vials
Product preparation, filling, closure and visual-inspection scope.
Explore proposed scope03PlannedCatalogue scope
Analytical method development
Product-specific test methods and analytical development questions.
Explore proposed scope05 · Readiness questions
A service claim needs a defined evidence base.
- Expression systems
- Exact cell lineage, genetic stability profile and the intended cultivation parameters.
- Facility qualification
- Relevant installed bioreactors, isolation trains and an approved spatial segregation model.
- Process definition
- Established downstream parameters, column lifecycles and the required viral clearance validation.
- Quality accountability
- Controlled testing boundaries, precise analytical scope, review and formal decision rights.
- Regulatory permissions
- Applicable environmental and biological processing approvals for the intended raw-material activity.
- Technical agreement
- Responsibilities, disclosure boundaries and defined limits for any future technical engagement.
06 · Practical questions
Before a technical discussion.
Is this service currently available?
No. The service is Planned. This page is a scope proposal and does not establish an operating protein raw-material production or purification service.
Does every biological process belong to the initial Boten plan?
No. The initial plan specifies protein raw-material production. Other biological formats and derivatives in the wider catalogue require separate scope confirmation before progressing.
What information helps define the question?
Identify the proposed biological molecule, development stage, intended destination and the technical question. Confidential data should only be shared through an agreed route.
Is there a service launch quarter?
No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual domain to a start date.
Does a technical discussion establish supply?
No. Feasibility, scope, regulatory permissions, process evidence and a technical agreement would need to be established before a supply commitment.
Professional enquiries
Discuss a defined question.
Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.